Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2006
12/13/2006EP1730150A2 Preparation of metal mesoporphyrin halide compounds
12/13/2006EP1730149A1 Novel naphthalene derivatives and coloring agents containing these compounds, for keratin fibers
12/13/2006EP1730148A2 Aminobenzoxazoles as therapeutic agents
12/13/2006EP1730122A2 Pyrimidine derivatives and methods of treatment related to the use thereof
12/13/2006EP1730119A1 Imidazole compounds for the treatment of neurodegenerative disorders
12/13/2006EP1730114A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
12/13/2006EP1729776A1 Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists
12/13/2006EP1729763A2 Novel bicyclic compounds as modulators of androgen receptor function and method
12/13/2006EP1446127B1 Triazepine derivatives as neurotrophic agents
12/13/2006EP1385823B1 Guanidino compounds as melanocortin-4 receptor (mc4-r) agonists
12/13/2006EP1294823B1 Double-spiro organic compounds and electroluminescent devices
12/13/2006CN1878845A Allergen decomposer and antiallergenic feather
12/13/2006CN1878774A Method for preparing cucurbiturils
12/13/2006CN1878773A Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligands
12/13/2006CN1878772A Bicyclic pyrazolone cytokine inhibitors
12/13/2006CN1878771A Substituted bicyclic quinazolin-4-ylamine derivatives
12/13/2006CN1878766A Methods for synthesizing quinolinone compounds
12/13/2006CN1878758A Crf antagonists and heterobicyclic compounds
12/13/2006CN1876627A Method for producing phthalocyanine compound and its intermediate and intermediate compound for the same
12/13/2006CN1289501C Fused heterotricyclic compound, process for preparing compounds and drugs containing the same
12/13/2006CN1289500C Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
12/13/2006CN1289499C Pirazino (aza) indole derivatives
12/12/2006US7148523 Molecular rectifier device
12/12/2006US7148351 Antiscaling agents
12/12/2006US7148350 Compounds in the form of homodimeric or heterodimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterases-mediated diseases or dysfunction
12/12/2006US7148349 Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs
12/12/2006US7148348 Process for preparing pyrrolotriazine aniline compounds useful as kinase inhibitors
12/12/2006US7148345 For use in inkjet inks
12/12/2006US7148237 Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
12/12/2006US7148228 Heat Shock Protein 90 (HSP90); inflammatory, autoimmune, neurological, cardiac fibrogenetic and proliferative disorders and infections, tumors, leukemias, neoplasms, cancers, carcinomas, stroke, ischemia, metabolic diseases, and malignant disease
12/12/2006US7148227 Fungicidal triazolopyrimidines, methods for producing the same, use thereof for combating harmful fungi and agents containing said substances
12/12/2006US7148226 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
12/12/2006US7148224 Pyrazinone derivatives
12/12/2006US7148220 Tyrosine kinase enzyme inhibitors as growth factor receptors and useful as antiproliferation agents
12/12/2006US7148219 Biaryl heterocyclic compounds and methods of making and using the same
12/12/2006US7148217 Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
12/12/2006US7148215 Prodrugs as antihistamines or anticarcinogenic agents
12/12/2006US7148214 Antihistaminic spiro compounds
12/12/2006CA2326716C Triazolopurine derivative, pharmaceutical composition containing the derivative, adenosine a3 receptor ligand, and remedy for asthma
12/12/2006CA2201435C Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido [1,2a]indol - carbocylic acids and their activated derivatives
12/07/2006WO2006129626A1 Method for producing [1,2,4]triazolo[1,5-c]pyrimidine derivative
12/07/2006WO2006076455A3 Processes for preparing pyrazolo[3,4-d]pyrimidine ethers
12/07/2006WO2006075094A3 Purine derivatives compositions containing the same and use thereof against cancer
12/07/2006WO2006068954A3 PYRAZOLO[1,5-A]PYRIMIDINE ADENOSINE A2a RECEPTOR ANTAGONISTS
12/07/2006WO2006068760A3 Anti-inflammatory pyrazolopyrimidines
12/07/2006WO2006058088A3 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
12/07/2006WO2005112919A8 Self-immolative linkers and drug conjugates
12/07/2006WO2005112919A2 Self-immolative linkers and drug conjugates
12/07/2006WO2005067546A3 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
12/07/2006WO2005056523A3 Methodology for preparing combinatorial libraries based upon a bicyclic scaffold
12/07/2006US20060276646 MAP kinase inhibitors; treating arthritis, ankylosing spondylitis, psoriatic arthritis, various gastrointestinal disorders; adult respiratory distress syndrome, asthma, COPD and Alzheimer's disease.
12/07/2006US20060276645 Novel carboxylic acid derivatives, their preparation and use
12/07/2006US20060276497 Novel multicyclic compounds and the use thereof
12/07/2006US20060276478 Pyrazolopyrimidines
12/07/2006US20060276475 Triazolotriazines and pyrazolotriazines and methods of making and using the same
12/07/2006US20060276474 Novel carboxylic acid derivatives, their preparation and use
12/07/2006US20060276471 Useful in therapy and treatment of diseases associated with a disregulated protein kinase activity like cancer; Aurora kinases
12/07/2006US20060276470 (+-)-7-Methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]pyrimidin-4-one, for example; selective inhibitors of phosphoinositide (PI) 3-kinase beta for use in anti-thrombotic therapy
12/07/2006US20060276457 Piperazine-piperidines with CXCR3 antagonist activity
12/07/2006US20060276456 Such as [1,1-biphenyl]-4-yl-(5,11-dihydro-10H-dibenzo[b,e][1,4]diazepin-10-yl)methanone; for treatment of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or hemophilia
12/07/2006US20060276453 and Mitogen-Activated Protein Kinase-Activated Protein kinase-2 (MAPKAP-k2 inhibitors, used for preventing or treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease
12/07/2006US20060276451 Inhibitors of production of cytokines interleukin-2 (IL-2) and tumor necrosis factor- alpha (TNF- alpha)
12/07/2006US20060276444 Porphyrin-polyamine conjugates for cancer therapy
12/07/2006US20060276408 Thrombin inhibitors; protease inhibition, kinase inhibition, CAAX inhibition, interference with peptides binding to SH2 domains and inhibition of MCH-I and/or MHC II presentation of peptides to T cell receptors
12/06/2006EP1729126A1 Water detection composition and water detection indicator
12/06/2006EP1728782A2 Monomers and network polymers obtained therefrom
12/06/2006EP1727821A1 Substituted diazabicycloheptanes and their use as protein kinase inhibitors
12/06/2006EP1727820A2 Amine derivatives
12/06/2006EP1727808A2 Biaryl amino acids and their use in dna binding oligomers
12/06/2006EP1218381B1 AMINO SUBSTITUTED PYRAZOLO¬1,5-a|-1,5-PYRIMIDINES AND PYRAZOLO¬1,5-a|-1,3,5-TRIAZINES
12/06/2006EP1137411B1 Palladium-substituted bacteriochlorophyll derivatives and use thereof
12/06/2006EP1091738B1 BICYCLIC sPLA 2 INHIBITORS
12/06/2006CN1874995A 2-halogen-6-alkyl-phenyl substituted tetramic acid derivatives
12/06/2006CN1873396A Water detection composition and water detection indicator
12/06/2006CN1872858A Optical dye of phthalocyanine derivative, and application in recording medium
12/06/2006CN1872857A Reverse-turn mimetics and method relating thereto
12/06/2006CN1872856A Reverse-turn mimetics and method relating thereto
12/06/2006CN1872855A Method for synthesizeing aryl imidazo [2, 1 a] isoquinoline
12/06/2006CN1872854A Antibiotic in lactam class, and prepartion method
12/06/2006CN1288156C Nianzhou Strain and its use
12/06/2006CN1288155C Process for preparing optical active ketorolac
12/05/2006US7145046 Halogen-fluorine exchange or addition of HF to a C-C multiple bond in with a fluorination agent in the presence of an HF adduct of a monocyclic or bicyclic amine containing at least two nitrogen atoms at least one of which in in the ring
12/05/2006US7145012 Cannabinoid receptor ligands and uses thereof
12/05/2006US7145010 Tert-alkylphenoxy-substituted polycyclic compounds
12/05/2006US7145009 Pirazino(aza)indole derivatives
12/05/2006US7145008 Pyrimidine derivatives for the treatment of abnormal cell growth
12/05/2006US7144995 Fluorescent nitrogenous base and nucleosides incorporating same
12/05/2006US7144965 Halogenated styrene compounds and very low-loss polymers made therefrom
12/05/2006US7144914 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias
12/05/2006US7144913 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
12/05/2006US7144912 drugs such as (4-methoxy-5-(1H-indol-2yl-methylene)-2,2'-bi-1H-pyrrole) used as anticarcinogenic or antitumor agents
12/05/2006US7144896 heterocyclic imines such as 3-[6-(1-Methanesulfonyl-1-methyl-ethyl)-quinolin-8-yl]-N-[6-(4-methylsulfanyl-phenyl)-pyridin-3-yl]-benzamide, used as phosphodiesterases (pde4) inhibitors; side effect reduction
12/05/2006US7144887 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
12/05/2006US7144883 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
12/05/2006US7144879 Substituted metal-phthalocyanines, their preparation and the use thereof
12/05/2006US7144843 For plants; fungicides
12/05/2006CA2434386C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
12/05/2006CA2245728C Isoquinoline derivatives and drugs
12/05/2006CA2203078C 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]indoles as estrogenic agents
11/2006
11/30/2006WO2006128184A2 Pyrimidine or triazine fused bicyclic metalloprotease inhibitors